-- 
Acrux Says Europe Marketing Authorization for Recuvyra Granted

-- B y   V i c t o r i a   B a t c h e l o r
-- 
2011-10-12T23:30:25Z

-- http://www.bloomberg.com/news/2011-10-12/acrux-says-europe-marketing-authorization-for-recuvyra-granted.html
Acrux Ltd. (ACR)  said the European
Medicines Agency has granted the marketing authorization for
commercial use of Recuvyra 50 mg/mL transdermal solution for
dogs, according to a regulatory filing.  To contact the editor responsible for this story:
Victoria Batchelor at 
 vbatchelor@bloomberg.net  